ArticleNature communications2023

Intranasal trimeric sherpabody inhibits SARS-CoV-2 including recent immunoevasive Omicron subvariants.

Anna R Mäkelä et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.